Chartwell Pharmaceuticals
Kundu Kundu is an experienced analytical chemist currently serving as a Senior Analytical Chemist in Quality Control at Chartwell Pharmaceuticals since March 2023, specializing in the validation, verification, and transfer of USP compendial test methods for drug products. Previously, Kundu held roles including Senior Analytical Scientist at Akorn Pharmaceuticals, where responsibilities included analytical support for marketing drug products and method validation, and Pharmaceutical Analytical Specialist at Teva/Actavis Pharmaceuticals, providing analytical support for critical investigations. Other positions include Senior Analytical Chemist at Novartis Pharmaceutical Inc., Senior Chemist at Teva Pharmaceuticals, Research Chemist at Purdue Pharma, and QC Chemist at Interpharm. Kundu holds a Master of Science in Chemistry from The City College of New York, as well as master's and bachelor's degrees in Applied Chemistry from Rajshahi University, Bangladesh.
Chartwell Pharmaceuticals
CHARTING A COURSE TO WELLNESS Chartwell Pharmaceuticals is a US-based development, manufacturing and commercial organization located in Congers, New York. Our facility produces prescription pharmaceutical products with a commitment to superior quality, compliance, and customer service. Chartwell Pharmaceuticals has a long history as a preferred manufacturing partner for prescription solid dosage products in tablet, capsule, and powders forms. Recent expansion now adds capabilities for suspensions, enemas and liquids manufacturing - including Unit Dose cups. Our rooms are large, our ceilings are high, and facilities are pristine. Our exceptional hands-on leadership team and technical staff bring decades of pharmaceutical industry experience in manufacturing and analytical services for development, scale-up, transferring, changing, launching, and supplying products. Under our own Chartwell labels, our mission is to provide a consistent, timely and quality product supply to our pharmacy customers and their patients. Our current portfolio stands at over 250 Orange Book listed ANDAs and NDAs, with an aggressive asset development and acquisition program in place. Supported by Chartwell Labs, our Formulations and Analytical team, we are quickly continuing to broaden our line through commercial Chartwell-labeled branding. Chartwell Pharmaceuticals is proud to be manufacturing "Made in the USA" products.